2022 American Transplant Congress » Cirrhosis: Complications, Portal Hypertension and Renal Management

Date: Sunday, June 5, 2022

Time: 5:30pm-7:00pm

Location: Hynes Room 311

Session Type: Rapid Fire Oral Abstract

Meeting: 2022 American Transplant Congress

5:30pm-5:40pm: Gender Affects the Association Between Serum Creatinine Levels and Clinical Response to Terlipressin in Patients with Hepatorenal Syndrome Type of Acute Kidney Injury

K. Jamil¹, R. Frederick², S. Pappas³

5:40pm-5:50pm: Transjugular Intrahepatic Portosystemic Shunt Placement is Associated with Increased All-Cause and Cardiac Mortality in Those Undergoing Liver Transplant for Nonalcoholic Steatohepatitis

D. U. Lee¹, J. Han², J. Kwon², K. Chang², G. Fan², K. Lee¹, N. Urrunaga³, C. Bhati¹, D. Maluf³, K. Shetty³

5:50pm-6:00pm: Liver Transplantation in Patients with Portal Vein Thrombosis: Implications and Outcomes

D. Noguchi, C. J. Rosenthal, M. Ha, V. G. Agopian, D. G. Farmer, F. M. Kaldas

6:00pm-6:10pm: Kidney Transplant Alone Recipients with Advanced Liver Disease Have Similar Outcomes to Those without Advanced Liver Disease

R. R. Nathani, S. M. Rutledge, C. Villarroel, R. Shapiro, G. Y. Im

6:10pm-6:20pm: Patient-Reported Physical Function Correlates with Liver Frailty Index and 4-Meter Gait Speed in Patients with Cirrhosis

A. J. Thuluvath, J. Peipert, K. Belfanti, S. Morrissey, O. Siddiqui, J. Levitsky, Z. Dietch, A. Flores, D. P. Ladner

6:20pm-6:30pm: Long-Term Outcomes of Crossmatch Positive Simultaneous Liver Kidney Transplants in the United States

S. Riad¹, E. Aby¹, S. Jackson², P. Nguyen³, N. Lim¹, J. Lake¹

6:30pm-6:40pm: Renal Failure is Reversible in the Majority of Patients Transplanted for Alcohol-Associated Hepatitis: A Review of the UNOS Database

Y. Bekki, G. Im, T. Schiano, S. Florman

6:40pm-6:50pm: Race-Based Differences in Simultaneous Liver and Kidney Transplant Utilization and Outcomes

L. Subbaraj¹, J. Lai², G. Cullaro²

6:50pm-7:00pm: Higher Baseline Serum Creatinine Levels AreAssociated with an Increased Incidence of Renal Replacement Therapy in Patients with Hepatorenal Syndrome Type 1 on the Liver Transplant Waitlist

S. N. Sclair¹, A. Befeler², K. Jamil³

« View all sessions from the 2022 American Transplant Congress